Guarini, A.; Radice, G.; Peragine, N.; Buracchi, C.; De Propris, M.S.; Di Rocco, A.; Di Rocco, A.; Chiaretti, S.; Moretti, A.; Napolitano, S.;
et al. Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia. Cancers 2023, 15, 2411.
https://doi.org/10.3390/cancers15092411
AMA Style
Guarini A, Radice G, Peragine N, Buracchi C, De Propris MS, Di Rocco A, Di Rocco A, Chiaretti S, Moretti A, Napolitano S,
et al. Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia. Cancers. 2023; 15(9):2411.
https://doi.org/10.3390/cancers15092411
Chicago/Turabian Style
Guarini, Anna, Giulia Radice, Nadia Peragine, Chiara Buracchi, Maria Stefania De Propris, Alice Di Rocco, Arianna Di Rocco, Sabina Chiaretti, Alex Moretti, Sara Napolitano,
and et al. 2023. "Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia" Cancers 15, no. 9: 2411.
https://doi.org/10.3390/cancers15092411
APA Style
Guarini, A., Radice, G., Peragine, N., Buracchi, C., De Propris, M. S., Di Rocco, A., Di Rocco, A., Chiaretti, S., Moretti, A., Napolitano, S., Martelli, M., Balduzzi, A., Gaipa, G., Biondi, A., & Foà , R.
(2023). Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia. Cancers, 15(9), 2411.
https://doi.org/10.3390/cancers15092411
